Date: 2016-08-29
Type of information: Production agreement
Compound: undisclosed product
Company: BioInvent (Sweden) undisclosed major global pharmaceutical company
Therapeutic area: Technology - Services
Type agreement: production manufacturing
Action mechanism:
Disease:
Details: * On August 29, 2016, BioInvent International announced that it has signed an extended contract for manufacturing services with one of its current customers, a major global pharmaceutical client. The extension covers services for one of the products in the pharmaceutical company’s development portfolio. This new agreement is expected to generate about SEK 8 million in revenue, with the majority occurring in 2016.
Financial terms:
Latest news:
